Huge thrombus formation 1 year after percutaneous closure of an atrial septal defect with an Amplatzer septal occluder

References (10)

1. Cooke J, Gelman J, Menahem S, Harper RW. Thrombus on an ASD clo-sure device: a call for caution. Heart, Lung Circ 2000; 9: 30-1
2. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1000 consecutive patients. J Am Coll Cardiol 2004; 43: 302-9
3. Bonou M, Lampropoulos KM, Barbetseas J. Thrombus formation 10 years after placement of an atrial septal secundum defect closure device. Eur Heart J 2012; 33: 704
4. Majunke N, Bialkowski J, Wilson N, Szkutnik M, Kusa J, Baranows-ki A, et al. Closure of atrial septal defect with the Amplatzer septal occluder in adults. Am J Cardiol 2009; 103: 550-4
5. Cetta F, Arruda MJ, Graham LC. Large left atrial thrombus formation despite warfarin therapy after device closure of a patent foramen ovale. Cathet Cardiovasc Intervent 2003; 59: 396–8
6. Snijder RJ, Suttorp MJ, Berg JM, Post MC. Percutaneous closure of secundum type atrial septal defects: More than 5-year follow-up. World J Cardiol 2015; 7: 150-6
7. Sherman JM, Hagler DJ, Cetta F. Thrombosis after septal closure device placement: a review of the current literature. Catheter Cardiovasc Interv 2004; 63: 486-9
8. Olabiyi OO, Morales DL, Franklin WJ. De novo thrombus on an atrial septal defect device 3 years after its implantation. Pediatr Cardiol 2013; 34: 1269-71
9. Khairy P, O’Donnell CP, Landzberg MJ. Transcatheter clsoure versus medical therapy of patent foramen ovale and presumed paradoxi-cal thromboemboli. Ann Intern Med 2003; 139: 753–60
10. Chessa M, Butera G, Frigiola A, Carminati M. Endothelialization of ASD devices for transcatheter closure: possibility or reality? Int J Cardiol 2004; 97: 563-4.